Cargando…

Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro

Angiopoietin-2 (Ang2) is a key proangiogenic factor, but its role in surgery-induced angiogenesis, a possible cause of cancer recurrence, is still elusive. We measured the plasma Ang2 levels in healthy controls (n = 42) and stage I–IV perioperative nonsmall cell lung cancer (NSCLC) patients (n = 227...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Leng, Lan, Haidan, Zhou, Qinghua, Yue, Jianming, Liu, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985320/ https://www.ncbi.nlm.nih.gov/pubmed/27512865 http://dx.doi.org/10.1097/MD.0000000000004493

Ejemplares similares

The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: A meta-analysis
por: Xu, Yuyang, et al.
Publicado: (2017)

Angiogenesis inhibitors for the treatment of small cell lung cancer (SCLC): A meta-analysis of 7 randomized controlled trials
por: Li, Qing, et al.
Publicado: (2017)

Relationship between quantitative contrast-enhanced ultrasonography parameters and angiogenesis in primary small hepatocellular carcinoma: A retrospective study
por: Deng, Shuhao, et al.
Publicado: (2021)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

Clinicopathological Analysis of Factors Related to Colorectal Tumor Perforation: Influence of Angiogenesis
por: Medina-Arana, Vicente, et al.
Publicado: (2015)

High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis
por: Deng, Han-Yu, et al.
Publicado: (2021)

Plasma lncRNA FEZF1-AS1 as a potential biomarker for diagnosis of non-small-cell lung carcinoma
por: Huang, Yajie, et al.
Publicado: (2020)

Continuous infusion of high‐dose ulinastatin during surgery does not improve early postoperative clinical outcomes in patients undergoing radical lung cancer surgery: A pilot study
por: Zhou, Leng, et al.
Publicado: (2016)

Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer: A systematic review
por: Pu, Dan, et al.
Publicado: (2020)

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020)

Elevated pretreatment neutrophil-to-lymphocyte ratio indicate low survival rate in apatinib-treated patients with non-small cell lung cancer: A STROBE-compliant article
por: Wan, Ya-Nan, et al.
Publicado: (2022)

Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Retrospective Study of 164 Cases
por: Bai, Huimin, et al.
Publicado: (2015)

Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting
por: Leng, Jiao, et al.
Publicado: (2019)

Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology
por: Chu, Meiling, et al.
Publicado: (2023)

Microvessel density as a prognostic factor in esophageal squamous cell cancer patients: A meta-analysis
por: Ma, Guangzhi, et al.
Publicado: (2017)

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy
por: Xu, Shuyuan, et al.
Publicado: (2019)

Nomograms for predicting overall survival and cancer-specific survival in patients with head and neck non-Hodgkin lymphoma: A population-based study
por: Peng, Jing, et al.
Publicado: (2023)

Metabolic Syndrome and Risk of Cervical Human Papillomavirus Incident and Persistent Infection
por: Huang, Xin, et al.
Publicado: (2016)

Elevated Preoperative Serum Hs-CRP Level as a Prognostic Factor in Patients Who Underwent Resection for Hepatocellular Carcinoma
por: Liu, Yu-Bin, et al.
Publicado: (2015)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

The combination of platelet count and lymphocyte to monocyte ratio is a prognostic factor in patients with resected breast cancer
por: Deng, Yunfu, et al.
Publicado: (2020)

Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis
por: Mo, Huaqing, et al.
Publicado: (2021)

Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
por: Hu, Yongqi, et al.
Publicado: (2022)

Synchronous diffuse large B-cell lymphoma of the stomach and small cell lung carcinoma: A case report
por: Li, Jia, et al.
Publicado: (2017)

Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report
por: Liu, Liang, et al.
Publicado: (2021)

A case report of immune checkpoint inhibitor nivolumab combined with anti-angiogenesis agent anlotinib for advanced esophageal squamous cell carcinoma
por: Tang, Yong, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

Small cell lung cancer treated by radiofrequency ablation: A case report
por: Song, Guo-qiang, et al.
Publicado: (2017)

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015)

Metastatic spread of solid subtype lung adenocarcinoma to the small intestine with anemia and melena: A case report
por: Ying, Xiaofang, et al.
Publicado: (2017)

Adjuvant Therapeutic Modalities in Primary Small Cell Carcinoma of Esophagus Patients: A Retrospective Cohort Study of Multicenter Clinical Outcomes
por: Zou, Bingwen, et al.
Publicado: (2016)

Glycation of Tie-2 Inhibits Angiopoietin-1 Signaling Activation and Angiopoietin-1-Induced Angiogenesis
por: Zhou, Haiyan, et al.
Publicado: (2022)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer: A PRISMA-compliant meta-analysis and systematic review
por: Zhou, Shunkai, et al.
Publicado: (2020)

Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) combined with bevacizumab for advanced non-squamous non-small-cell lung cancer patients with gradual progression on EGFR-TKI treatment: A cohort study
por: Yu, Yuman, et al.
Publicado: (2021)

Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma
por: Oba, Junna, et al.
Publicado: (2016)

Effects of clinicopathological factors on prognosis of young patients with resected breast cancer
por: Li, Wen, et al.
Publicado: (2021)

Integrated analysis of competitive endogenous RNA networks in elder patients with non-small cell lung cancer
por: Chen, Zi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0e22q7huk4fm4qk2be43nm321